Literature DB >> 17423691

Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia.

K A Mathews, T Doherty, D H Dyson, B Wilcock, A Valliant.   

Abstract

Uremia unexpectedly developed in five dogs 24 hours after undergoing thoracotomy in a student laboratory. In all dogs general anesthesia had been maintained with methoxyflurane, muscle relaxation had been induced with gallamine, and each dog received a single intravenous dose of 1.0 mg/kg flunixin meglumine for analgesia upon termination of anesthesia. In a subsequent group of dogs undergoing an orthopedic procedure, we assessed the effects on renal function of methoxyflurane anesthesia plus oxymorphone, or of methoxyflurane or halothane anesthesia in combination with a single IM 1.0 mg/kg dose of flunixin meglumine. Significant elevations in serum urea and creatinine values, and necrosis of collecting ducts and loops of Henle, were noted only in the dogs receiving methoxyflurane and flunixin meglumine.We conclude that the use of combination of methoxyflurane and flunixin meglumine is contraindicated in dogs.

Entities:  

Year:  1990        PMID: 17423691      PMCID: PMC1480876     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  18 in total

1.  Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney.

Authors:  S I Rubin
Journal:  J Am Vet Med Assoc       Date:  1986-05-01       Impact factor: 1.936

2.  Serum fluoride concentration, renal, and hepatic function test results in dogs with methoxyflurane anesthesia.

Authors:  W M Pedersoli
Journal:  Am J Vet Res       Date:  1977-07       Impact factor: 1.156

3.  Non-steroidal anti-inflammatories in dogs.

Authors:  J S Fowler
Journal:  Vet Rec       Date:  1987-04-25       Impact factor: 2.695

4.  Fluoride and methoxyflurane nephropathy.

Authors:  J B Hook
Journal:  Anesthesiology       Date:  1971-09       Impact factor: 7.892

5.  Pharmacokinetics of flunixin meglumine in dogs.

Authors:  E M Hardie; G E Hardee; C A Rawlings
Journal:  Am J Vet Res       Date:  1985-01       Impact factor: 1.156

6.  Pancuronium reduces halothane requirement in man.

Authors:  A R Forbes; N H Cohen; E I Eger
Journal:  Anesth Analg       Date:  1979 Nov-Dec       Impact factor: 5.108

7.  Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2.

Authors:  L G Collins; D E Tyler
Journal:  Am J Vet Res       Date:  1985-08       Impact factor: 1.156

8.  Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs.

Authors:  N A Terragno; D A Terragno; J C McGiff
Journal:  Circ Res       Date:  1977-06       Impact factor: 17.367

9.  Effects of flunixin meglumine and dexamethasone on aqueous protein values after intraocular surgery in the dog.

Authors:  S D Krohne; W A Vestre
Journal:  Am J Vet Res       Date:  1987-03       Impact factor: 1.156

Review 10.  Arachidonic acid metabolism, prostaglandins and the kidney.

Authors:  D J Levenson; C E Simmons; B M Brenner
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

View more
  4 in total

Review 1.  Nonsteroidal anti-inflammatory analgesics in pain management in dogs and cats.

Authors:  K A Mathews
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

2.  A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs.

Authors:  K A Mathews; D M Paley; R A Foster; A E Valliant; S S Young
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

3.  The effects of perioperative analgesia on litter size in Crl:CD1(ICR) mice undergoing embryo transfer.

Authors:  David R Goulding; Page H Myers; Eugenia H Goulding; Terry L Blankenship; Mary F Grant; Diane B Forsythe
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

4.  Evaluation of the adverse effects of oral firocoxib in healthy dogs.

Authors:  P V M Steagall; F B Mantovani; T H Ferreira; E S Salcedo; F Q Moutinho; S P L Luna
Journal:  J Vet Pharmacol Ther       Date:  2007-06       Impact factor: 1.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.